Cited by 266Substance Abuse Treatment and OutcomesSchizophrenia research and treatmentForensic Toxicology and Drug Analysis

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Methamphetamine Psychosis: Epidemiology and Management

Open access

Glasner-Edwards, Suzette, Mooney, Larissa J.·2014·CNS Drugs

DOI 10.1007/s40263-014-0209-8PMC PMC5027896

Open this paper in CoChat — free account

Abstract

Psychotic symptoms and syndromes are frequently experienced among individuals who use methamphetamine, with recent estimates of up to approximately 40 % of users affected. Although transient in a large proportion of users, acute symptoms can include agitation, violence, and delusions, and may require management in an inpatient psychiatric or other crisis intervention setting. In a subset of individuals, psychosis can recur and persist and may be difficult to distinguish from a primary psychotic disorder such as schizophrenia. Differential diagnosis of primary vs. substance-induced psychotic disorders among methamphetamine users is challenging; nevertheless, with careful assessment of the temporal relationship of symptoms to methamphetamine use, aided by state-of-the art psychodiagnostic assessment instruments and use of objective indicators of recent substance use (i.e., urine toxicology assays), coupled with collateral clinical data gathered from the family or others close to the individual, diagnostic accuracy can be optimized and the individual can be appropriately matched to a plan of treatment. The pharmacological treatment of acute methamphetamine-induced psychosis may include the use of antipsychotic medications as well as benzodiazepines, although symptoms may resolve without pharmacological treatment if the user is able to achieve a period of abstinence from methamphetamine. Importantly, psychosocial treatment for methamphetamine dependence has a strong evidence base and is the optimal first-line treatment approach to reducing rates of psychosis among individuals who use methamphetamines. Prevention of methamphetamine relapse is the most direct means of preventing recurrence of psychotic symptoms and syndromes. Long-term management of individuals presenting with recurrent and persistent psychosis, even in the absence of methamphetamine use, may include both behavioral treatment to prevent resumption of methamphetamine use and pharmacological treatment targeting psychotic symptoms. In addition, treatment of co-occurring psychiatric disorders including depression and anxiety is important as a means of preventing relapse to methamphetamine use, which is often triggered by associated symptoms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s40263-014-0209-8

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
National Institute of Mental Health Diagnostic Interview Schedule: Its History, Characteristics, and Validity
Robins, L. N. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780290015001 · Cited by 5,219
The Composite International Diagnostic Interview: An Epidemiologic Instrument Suitable for Use in Conjunction With Different Diagnostic Systems and in Different Cultures
Robins, L. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360017003 · Cited by 2,909
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
Leucht, S., Pitschel‐Walz, G., Abraham, D., & Kissling, W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00105-4 · Cited by 795
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 535
Dr. Gilberto Gerra, Chief of Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime (UNODC), Vienna.
Gerra, G. (2013) · Cited by 529
Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 502
Addictions: A Comprehensive Guidebook
McCrady, B. S., & Epstein, E. E. (2013) · Cited by 488

Flagged first, then by citations

Show all 97 references

Research works printed but not linked: 6

World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders. Geneva: Diagnostic Criteria For Research; 1992.
Connell PH. Amphetamine psychosis. Maudsley Monograph No. 5, London: Oxford University Press; 1958.
Volkow ND. NIDA research report: methamphetamine abuse and addiction. Washington: National Institute on Drug Abuse; 2006.
Wada K, Fukui S. Residual symptoms in methamphetamine psychosis. J Mental Health. 1991;37:161–8.
First MB, Spitzer RL, Williams JEW, et al. Structured Clinical Interview for DSM-IV-Clinician Version (SCID-CV) (User’s guide and interview). Washington, DC: American Psychiatric Press; 1997.
Rawson RA. Methamphetamine: new knowledge, new treatments. Center City, MN: Hazelden; 2006.

Sorted by citations

Items 101–200 of 266

Single‐nucleus transcriptome profiling of prefrontal cortex induced by chronic methamphetamine treatment
Zeng, K., Yu, X., Wei, Z., Wu, Y., Wang, J., Liu, R., Li, Y., & Wang, X. (2023) · General Psychiatry · doi:10.1136/gpsych-2023-101057 · Cited by 8
Identification of the circRNA–miRNA–mRNA network for treating methamphetamine‐induced relapse and behavioral sensitization with cannabidiol
Liu, L., Wang, C., Wang, H., Miao, L., Xie, T., Tian, Y., Li, X., Huang, Y., Zeng, X., & Zhu, B. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14737 · Cited by 8
Optimizing outpatient treatment outcomes among methamphetamine-using gay and bisexual men through a computerized depression intervention
Fletcher, J. B., & Reback, C. J. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108663 · Cited by 8
Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairmentPreprint
Hagihara, H., Shoji, H., Hattori, S., Sala, G., Takamiya, Y., Tanaka, M., Ihara, M., Shibutani, M., Hatada, I., Hori, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.02.428362 · Cited by 8
Factors Associated with Psychotic and Depressive Symptoms in Methamphetamine Users
Karabulut, S. (2023) · Iranian Journal of Psychiatry · doi:10.18502/ijps.v19i1.14334 · Cited by 7
Diagnosis of methamphetamine‐induced psychotic disorder: Findings of an expert consensus panel
Camfield, K., Reedy, A., Wolf, C., Al‐Tayyib, A., Rinehart, D. J., Simpson, S. A., & Panel, F. T. B. M. M. E. (2024) · Early Intervention in Psychiatry · doi:10.1111/eip.13547 · Cited by 7
The Effect of Repetitive Transcranial Magnetic Stimulation on the Reinstatement of Methamphetamine-Induced Conditioned Place Preference in Rats.
Wu, X.-Q., Ju, Y., Jiao, D., & Zhao, M. (2018) · Europe PMC (PubMed Central) · doi:10.11919/j.issn.1002-0829.218007 · Cited by 7
Methamphetamine in Orthopaedics
Cornwell, D. Q., Thompson, A. R., Ivie, R. M. J., Working, Z. M., Friess, D., & Meeker, J. E. (2021) · JBJS Reviews · doi:10.2106/jbjs.rvw.20.00229 · Cited by 7
Differences in small-world networks between methamphetamine and heroin use disorder patients and their relationship with psychiatric symptoms
Liu, Y., Li, Q., Zhang, T., Wang, L., Wang, Y., Chen, J., Zhu, J., Shi, H., Wang, W., & Li, W. (2022) · Brain Imaging and Behavior · doi:10.1007/s11682-022-00667-0 · Cited by 7
Analysis of Acute and Chronic Methamphetamine Treatment in Mice on Gdnf System Expression Reveals a Potential Mechanism of Schizophrenia Susceptibility
Casserly, L., Garton, D. R., Montaño-Rodriguez, A., & Andressoo, J. (2023) · Biomolecules · doi:10.3390/biom13091428 · Cited by 7
The Role of Chinese Herbal Therapy in Methamphetamine Abuse and its Induced Psychiatric Symptoms
Chen, L., Ru, Q., Xiong, Q., Zhou, M., Yue, K., & Wu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.679905 · Cited by 7
Caring for Hospitalized Adults with Methamphetamine Use Disorder: A Proposed Clinical Roadmap
Priest, K. C., Balasanova, A. A., Levander, X. A., Chan, B. L., Blazes, C. K., Mahan, J. D., Brown, J. A., Mahoney, S., Peng, L., Mahoney, S., et al. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2023.01.012 · Cited by 7
Disrupted betaine metabolism drives Th17 cell differentiation, mediating methamphetamine-induced depressive behaviors in male mice
Hui, R., Xu, J., Ma, H., Feng, T., Hou, C., Wang, X., Jin, M., Feng, Y., Shi, Y., Xie, B., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03532-1 · Cited by 6
A call for action: Closing the evidence gap in management of stimulant‐induced psychosis
Bouthillier, A., Sharafi, H., Bisaga, A. M., & Jutras‐Aswad, D. (2026) · Addiction · doi:10.1111/add.70393 · Cited by 6
The Opioid Interactions of the Antipsychotic Medications Risperidone and Amisulpride in Mice and Their Potential Use in the Treatment of Other Non-Psychotic Medical Conditions
Schreiber, S., & Pick, C. G. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01001-2 · Cited by 6
Initiation of Antipsychotic Treatment for Amphetamine Induced Psychosis and Its Impact on Length of Stay
Herbst, C., O’Connell, M., Melton, B. L., & Moeller, K. E. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900221110453 · Cited by 6
Characterising methamphetamine use to inform health and social policies in Manitoba, Canada: a protocol for a retrospective cohort study using linked administrative data
Nickel, N. C., Enns, J. E., Freier, A., McCulloch, S., Chartier, M., Casidsid, H. J. M., Balogun, O. D., Mulhall, D., Drăgan, R., Sarkar, J., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062127 · Cited by 6
Substance-Induced Psychosis and Co-occurring Psychotic Disorders
Brown, H. E., Kaneko, Y. A., & Donovan, A. L. (2019) · Current clinical psychiatry · doi:10.1007/978-3-319-23961-3_7 · Cited by 6
Schizophrenia Polygenic Risk and Brain Structural Changes in Methamphetamine-Associated Psychosis in a South African Population
Passchier, R. V., Stein, D. J., Uhlmann, A., van der Merwe, C., & Dalvie, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.01018 · Cited by 6
A Narrative Review of the Pathophysiology and Treatment of Methamphetamine-Associated Psychosis
Stacy, P. D., Frantz, J., Miller, G., Merrill, B., & Gainer, D. M. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01323-y · Cited by 5
Role of Glial Trace Amine Associated Receptor 1 (TAAR1) and Microbiota in Schizophrenia
Tsytsarev, V., Vaganova, A. N., Volnova, A. B., Fesenko, Z. S., Getachew, B., Gainetdinov, R. R., & Tizabi, Y. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04525-5 · Cited by 5
Inpatient Complications and Outcomes for Burn Patients Admitted With Methamphetamine Intoxication
Stanton, E. W., Karanas, Y. L., Pham, T. N., Gillenwater, J. T., & Sheckter, C. C. (2024) · Journal of Burn Care & Research · doi:10.1093/jbcr/irae014 · Cited by 5
The Effectiveness of Mindfulness in the Treatment of Methamphetamine Addiction Symptoms: Does Neuroplasticity Play a Role?
Chmiel, J., Malinowska, A., Rybakowski, F., & Leszek, J. (2024) · Brain Sciences · doi:10.3390/brainsci14040320 · Cited by 10
Methamphetamine-Related Emergency Department Visits Requiring Psychiatric Admission: A Retrospective Cohort Study
Bahji, A. (2020) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-020-00230-2 · Cited by 5
Treatment Response Distinguishes Persistent Type of Methamphetamine Psychosis From Schizophrenia Spectrum Disorder Among Inmates at Japanese Medical Prison
Sekiguchi, Y., Okada, T., & Okumura, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.629315 · Cited by 5
Aberrant expression of BDNF might serve as a candidate target for cocaine‐induced psychosis: insights from bioinformatics analysis and microarray validation
Zhu, Y., Zhao, Y., Xu, X., Su, H., Li, X., Zhong, N., Jiang, H., Du, J., & Zhao, M. (2021) · General Psychiatry · doi:10.1136/gpsych-2021-100587 · Cited by 5
Neuroenhancement: State of the Art and Future Perspectives.
Marazziti, D., Avella, M. T., Ivaldi, T., Palermo, S., Massa, L., Vecchia, A. D., Basile, L., & Mucci, F. (2021) · PubMed Central · doi:10.36131/cnfioritieditore20210303 · Cited by 6
Domestic Violence in Methamphetamine Psychotic Users, Psychiatric Inpatients, and Healthy People: A Comparative Study.
Khalkhali, S. M. R., Najafi, K., Ahmadi, R., Yousefnezhad, A., Hamidi, A., Ellahi, M. M., Amiri, A., Montakhabi, A., & Zavarmousavi, S. M. (2016) · Europe PMC (PubMed Central) · Cited by 5
Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up
Koutanaei, S. J., Shabani, A., & Shariat, S. V. (2016) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.16m02002 · Cited by 5
Psychiatric Issues in the Critically Poisoned Patient
Rasimas, J. J., & Carter, G. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-20790-2_44-1 · Cited by 5
Catechol-O-methyltransferase gene expression in stress-induced and non-stress induced schizophrenia
Aghamaleki-Sarvestani, Z., Vousooghi, N., Tabrizi, M. H., Alipour, M., Alaghband‐Rad, J., Abdolmaleky, H. M., & Zarindast, M. R. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000243 · Cited by 5
Stimulants: Caffeine, Cocaine, Amphetamine, and Other Stimulants
DeVido, J. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-33404-8_12 · Cited by 7
Scoping Review of Best Practice Guidelines for Care in the Labor and Birth Setting of Pregnant Women Who Use Methamphetamines
Gulbransen, K., Thiessen, K. R., Pidutti, J., Watson, H., & Winkler, J. (2021) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2021.10.008 · Cited by 5
The psychosis risk timeline: can we improve our preventive strategies? Part 2: adolescence and adulthood
Romain, K., Eriksson, A., Onyon, R., & Kumar, M. T. (2019) · BJPsych Advances · doi:10.1192/bja.2019.1 · Cited by 4
Flow Through the Emergency Department for Patients Presenting with Substance Use Disorder in Alberta, Canada
Edmundson, J., Skoblenick, K. J., & Rosychuk, R. J. (2023) · Western Journal of Emergency Medicine · doi:10.5811/westjem.60350 · Cited by 4
Perceived need for care and stigma experiences among individuals with methamphetamine-related admissions to inpatient mental health wards
Wilson, L., Karnik, N., Wong, J. Y., Barchet, L., Sareen, J., Jwely, A., Nickel, N. C., Konrad, G., Nepon, J., & Bolton, J. M. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00827-5 · Cited by 4
Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia
Mamat, R., Rashid, R. A., Sim, M. S., Ibrahim, B., Wahab, S. B., & Ahmad, A. (2023) · Journal of Addictive Diseases · doi:10.1080/10550887.2023.2240932 · Cited by 4
Crystal methamphetamine and its effects on mental and oral health: A narrative review
Alqarni, H., Aldghim, A., Alkahtani, R., Alshahrani, N. M., Altoman, M. S., Alfaifi, M. A., Helmi, M. F., & Alzaid, A. A. (2024) · The Saudi Dental Journal · doi:10.1016/j.sdentj.2024.02.011 · Cited by 4
Ten-year cardiovascular disease risk and related factors in lifetime marijuana use with comorbid methamphetamine-associated psychotic disorder: a QRISK®3 study
Örüm, D., Örüm, M. H., Kapıcı, Y., & Abuş, S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06018-1 · Cited by 4
Sedation and analgesia needs in methamphetamine intoxicated patients: much ado about nothing
Chiang, E. L., Case, J., Cook, M. R., Schreiber, M. A., Sorenson, C., & Barton, C. A. (2021) · Injury · doi:10.1016/j.injury.2021.10.021 · Cited by 3
“If You Plant That Seed, It Will Grow”: A Qualitative Study to Improve Linkage to Care Among Patients With Methamphetamine Use Disorder in Emergency Department Settings
Rinehart, D. J., Duarte, K. G., Gilbert, A., Al‐Tayyib, A., Camfield, K., & Simpson, S. A. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001315 · Cited by 3
Methamphetamine-related psychiatric emergencies in Türkiye: clinical features, risk factors, and follow-up results from a tertiary mental health center
Yalçın, M. E., & Paltun, S. C. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1675959 · Cited by 3
Association study of GABA system genes polymorphisms with amphetamine-induced psychotic disorder in a Han Chinese population
Zhang, K., Zhao, Y., Wang, Q., Jiang, H., Du, J., Yu, S., & Zhao, M. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.019 · Cited by 3
Rural Populations
Rekerdres, C. M., & Giggie, M. A. (2022) · Springer eBooks · doi:10.1007/978-3-031-10239-4_48 · Cited by 3
A Case Report of Treatment With Cariprazine in a Recurrent Psychosis Presumably Induced by Methamphetamine
Moran, R. A., Hastings, C., Della-Pietra, U., Singh, C., & Jacome, M. (2023) · Cureus · doi:10.7759/cureus.47135 · Cited by 3
Effect of Neurofeedback Training Along With Swimming Exercise on the Stress, Anxiety, Depression, Severity of Dependence, and Craving in Methamphetamine-Dependent Patients
Fadaei, A., Najafi, M., Miladi‐Gorji, H., Tajik‐Mansoury, M. A., & Afkar, M. (2024) · Journal of Clinical Sport Psychology · doi:10.1123/jcsp.2022-0011 · Cited by 4
The impact of methamphetamine on psychosocial variables in patients from Iraq
Abbass, M., Al-Hemiary, N. J., & Sahib, H. B. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1376636 · Cited by 3
Toxic Effects of Methamphetamine on Reproductive Systems, Embryo Development, and Newborns: An Evidence-based Review
Chen, Q., Wang, L., Zhang, J., Cheng, J., Lin, J., Peng, Y., Liu, Y., Zhang, C., Yan, J., & Niu, S. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673299759240603091021 · Cited by 4
Psychiatric Diagnoses and Treatment Preceding Schizophrenia in Adolescents Aged 9–17 Years
Kang-Yi, C. D., Chao, B., Teng, S., Locke, J. J., Mandell, D., Wong, Y. I., & Epperson, C. N. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00487 · Cited by 3
Extensive tissue necrosis of the tongue in a methamphetamine user: A case report
Shudo, A. (2021) · Special Care in Dentistry · doi:10.1111/scd.12580 · Cited by 3
Association of methamphetamine use with depressive symptoms and gender differences in this association: a meta-analysis
Yi-qin, H., Zhai, J., & Liu, Y. (2020) · Journal of Substance Use · doi:10.1080/14659891.2020.1736659 · Cited by 3
The Vulnerability to Methamphetamine Dependence and Genetics: A Case-Control Study Focusing on Genetic Polymorphisms at Chromosomal Region 5q31.3
Xiao, J., Ma, Y., Wang, X., Wang, C., Li, M., Liu, H., Han, W., Wang, H., Zhang, W., Wei, H., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.870322 · Cited by 3
Corpus-Based Discourse Analysis of a Reddit Community of Users of Crystal Methamphetamine: Mixed Methods Study
Lustig, A., & Brookes, G. (2023) · JMIR Infodemiology · doi:10.2196/48189 · Cited by 2
Identification of SAA1 in extracellular vesicles contribute to methamphetamine withdrawal
Fang, Y., Gao, Y., Shen, F., Zhu, Y., Wang, L., Chen, Z., Tang, J., & Liao, Y. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.029 · Cited by 2
Evaluating markers for methamphetamine use in electronic health records
Bacon, E., Loh, R. M., DeNardo, J., Rinehart, D. J., Simpson, S. A., & Al‐Tayyib, A. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112876 · Cited by 2
Low-frequency electroacupuncture attenuates methamphetamine-induced depressive-like behaviors and cognitive impairment via modulating neuroinflammation
Zhang, J., Hui, R., Xu, J., Zhang, L., Xie, B., Ma, C., Li, Y., Zou, Y., Wen, D., & Yu, X. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1652065 · Cited by 2
Methamphetamine‐Associated Pulmonary Arterial Hypertension: Impact, Mechanisms, and a Framework for Management
Sood, N., Weerasekare, J., Zhyvylo, I., Goncharova, E. A., & Marco, T. D. (2026) · Pulmonary Circulation · doi:10.1002/pul2.70242 · Cited by 2
Methamphetamine induces long-lasting dysbiosis of the gut microbiota
Ding, N., Zhu, S., Yue, L., Zhang, L., Liu, L., Wang, Q., Wang, C., Gao, Y., Yan, J., Tong, S., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03475-w · Cited by 2
Just the Facts: Substance induced psychosis
Barbic, D., Chakraborty, A. T., & Honer, W. G. (2020) · Canadian Journal of Emergency Medicine · doi:10.1007/s43678-020-00017-3 · Cited by 2
The association of FKBP5 polymorphisms with the severity of depressive disorder in patients with methamphetamine use disorders
Fang, T., Liu, M., Tian, X.-Y., Lu, G.-Y., Li, F. Y., Zhang, X., Liu, F., Hao, W., Wu, N., Li, H., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1147060 · Cited by 3
Enhanced methamphetamine sensitisation in a rat model of the brain-derived neurotrophic factor Val66Met variant: Sex differences and dopamine receptor gene expression
Jaehne, E. J., Semaan, H., Grosman, A., Xu, X., Schwarz, Q., & van den Buuse, M. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109719 · Cited by 2
Disorders due to Substance Use: Stimulants
Sevarino, K. A., & Farrell, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_26 · Cited by 3
A deep learning model for characterizing altered gyro-sulcal functional connectivity in abstinent males with methamphetamine use disorder and associated emotional symptoms
Jiang, P., Xiao, Z., Geng, T., Sun, J., Xu, J., Huang, X., Li, J., Kendrick, K. M., Jiang, X., & Gong, Q. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf062 · Cited by 2
Substance-Related and Addictive Disorders
Kosten, T. R., Newton, T. F., Garza, R. D. L., & Haile, C. N. (2014) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585625031.rh23 · Cited by 2
NRG1 Types Down Regulate in Methamphetamine and Heroin Dependent Patients
Shahbazi, A. (2017) · MOJ Addiction Medicine & Therapy · doi:10.15406/mojamt.2017.03.00030 · Cited by 2
Methamphetamine-Induced Psychosis
Crockford, D. N., Meunier, S., & Ghosh, S. M. (2019) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000068 · Cited by 2
Does Manganese Contribute to Methamphetamine-Induced Psychosis?
Richards, I., & Richards, J. (2020) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-020-00221-6 · Cited by 1
Psicose induzida por drogas recreativas: uma revisão de literatura
Medeiros, D. N., Ribeiro, J. F. D. S., & Trajano, L. A. D. S. N. (2021) · Research Society and Development · doi:10.33448/rsd-v10i2.12459 · Cited by 2
Methamphetamin
Betzler, F., & Köhler, S. (2017) · Springer eBooks · doi:10.1007/978-3-642-55125-3_67 · Cited by 2
Illicit and prescription drug use and psychotic experiences among university students in the United States
Oh, H. Y., Rajkumar, R. P., Banawa, R. A., Zhou, S., & Koyanagi, A. (2022) · Journal of Substance Use · doi:10.1080/14659891.2022.2098842 · Cited by 2
Comparison of Methamphetamine Induced Psychosis and Primary Psychotic Disorder: Scoping Review of Social Cognition
Diotte, F., Potvin, S., Lang, D. J., Abdel‐Baki, A., Spidel, A. L., Villeneuve, M., & Lecomte, T. (2022) · JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY · doi:10.29245/2578-2959/2022/2.1144 · Cited by 2
Differential Effects of Chronic Methamphetamine Treatment on High-Frequency Oscillations and Responses to Acute Methamphetamine and NMDA Receptor Blockade in Conscious Mice
Hudson, M., Foreman, J., Rind, G. S., Manning, E., Jones, N. C., & van den Buuse, M. (2022) · Brain Sciences · doi:10.3390/brainsci12111503 · Cited by 2
Update on Common Psychiatric Medications for Children
Sharma, A. (2018) · Pediatric Annals · doi:10.3928/19382359-20180702-01 · Cited by 2
Quercetin ameliorates mitochondrial dysfunction and mitigates methamphetamine-induced anxiety-like behaviorPreprint
Chen, F., Sun, J., Zhang, Y., Dai, Y., Zhang, Z., Chen, C., Zou, L., Zhang, Z., Wu, H., Tian, W., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.29.450268 · Cited by 2
Increased lipid peroxidation and lowered antioxidant defenses predict methamphetamine induced psychosisPreprint
Al‐Hakeim, H. K., Altufaili, M. F., Almulla, A. F., Moustafa, S. R., & Maes, M. H. J. (2022) · medRxiv · doi:10.1101/2022.10.26.22281566 · Cited by 2
Associations between methamphetamine and alcohol use disorder, suicidal ideation, and lowered quality of life in methamphetamine users
Jirakran, K., Maes, M. H. J., Buathong, N., & Kalayasiri, R. (2023) · Exploration of Medicine · doi:10.37349/emed.2023.00151 · Cited by 1
Effect of Neurofeedback Training Along with Swimming Exercise on the Electroencephalographic Changes and Visual Image-Induced Craving in Methamphetamine-Dependent Patients
Fadaei, A., Najafi, M., Miladi‐Gorji, H., Tajik‐Mansoury, M. A., & Afkar, M. (2023) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2023.886.4 · Cited by 1
Methamphetamine use shortens telomere length in male adults and rats
Lu, G., Fang, T., Li, X., Zhang, X., Liu, F., Wu, N., Liu, F., Hao, W., Ye, Q.-N., Cheng, L., et al. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111094 · Cited by 1
Assessment of resting cerebral perfusion between methamphetamine-associated psychosis and schizophrenia through arterial spin labeling MRI
Hwang, Z.-A., Li, C., Hsu, A., Wu, C. W., Chan, W. P., & Huang, M. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01857-1 · Cited by 1
DEMOGRAPHIC PROFILE, SUBSTANCE USE TRENDS AND ASSOCIATED PSYCHOTIC DISORDERS AMONG VETERANS WITH MENTAL HEALTH CONDITIONS: A RETROSPECTIVE COHORT STUDY OF US VETERANS
Obermann, J., Divadeenam, K., Flynn, A., Thakur, H., Singh, V., Sharma, R., Wiegmann, T. B., Boinpelly, V., Grasing, K., Sharma, M., et al. (2024) · ASEAN Journal of Psychiatry · doi:10.54615/2231-7805.47358 · Cited by 2
The dark side of “legal highs”: a case of psychosis in polysubstance use—A young psychonaut’s perspective
Marzolla, M., Menga, A., Romeo, F., & Gatti, R. (2025) · Journal of Substance Use · doi:10.1080/14659891.2025.2494534 · Cited by 1
Perioperative Stroke in MCA Aneurysm Surgery: The Hidden Risks of Amphetamine Use
Taskaya, F., Swiatek, V. M., Al-Hamid, S., Reiser, J., Schwab, R., Stein, K., Behme, D., Rashidi, A., Sandalcioglu, I. E., & Neyazi, B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093246 · Cited by 1
Use of Intramuscular Midazolam, Diphenhydramine, and Haloperidol in Acute Agitation Management in a Psychiatric Emergency Department
Williams, A. M., Mong, R., CHIJIWA, K., Alabadi-Bierman, A., Tran, B. Q., Huynh, P., Benbarka, T., & Allison-Aipa, T. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002027 · Cited by 1
Cannabis and Methamphetamine Use Patterns in a Psychiatric Inpatient Setting in Iran
Eyvaznejad, B., Eslami, M. H., Najafi, A., Gholami, J., Shadloo, B., & Rahimi‐Movaghar, A. (2025) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-157594 · Cited by 1
Distinct electroencephalogram microstate in patients with methamphetamine use disorder and obsessive-compulsive disorder
Zhu, R., Tian, Y., Jiang, L., Qu, M., Wang, D., & Zhang, X. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120392 · Cited by 1
Insomnia in stimulant use disorders: Prevalence and associations with negative affect
Bourtin, I. G., de Dios, C., Vincent, J. N., Schmitz, J. M., Lane, S. D., & Webber, H. E. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.108689 · Cited by 1
Three cases of drug-related death during treatment for stimulant-induced psychosis
NISHIO, T., Toukairin, Y., Hoshi, T., Arai, T., & Nogami, M. (2026) · Legal Medicine · doi:10.1016/j.legalmed.2026.102789 · Cited by 1
Alexithymia in Chinese methamphetamine dependent males: prevalence, demographic, clinical correlates, and relationship with craving
Kiyani, A. R. T., Zhang, X. Y., Bashir, M., Saad, U., & Wang, D.-M. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02146-1 · Cited by 1
Cannabidiol attenuates methamphetamine-induced psychosis via anti-oxidative stress: σ1R-mediated mitochondrial dysfunction as a critical pathway
Liu, L., Wang, C., Tian, Y., Yin, Y., Rao, M., Tao, H., Luo, C., Li, J., & Zeng, X. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158015 · Cited by 1
Prenatal methamphetamine exposure and fetal death: A retrospective autopsy-based study
Şahin, H. Ç., Buğra, A., Yaman, M. F., Kefçi, M. M., Koç, Ü., Asan, Ö., Kavla, Y., Ulu, E., Oruç, M. A., Özel, A., et al. (2026) · Forensic Science International · doi:10.1016/j.forsciint.2026.112986 · Cited by 1
Assessment of a directed care facility for substance use disorder treatment in Qatar
Ashton, N., Abdulla, M. A. Y. A. A., Samarasinghe, N., & Hazaa, H. A. H. J. B. (2026) · Drugs Habits and Social Policy · doi:10.1108/dhs-07-2025-0033 · Cited by 1
Emergency Medicine Settings
Tyler, K. R., Hirsch, C. H., Scher, L. M., & Stevenson, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-30346-8_16 · Cited by 1
Do adolescents and young adults accessing the Emergency Room with substance use receive poor therapeutic indications at discharge? An observational retrospective study
Molteni, L., Cafaro, R., Varinelli, A., Espa, I., Conde, M. M., Brambilla, A. M., Viganò, C. A., & Dell’Osso, B. M. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14890 · Cited by 1
Substance-Related and Addictive Disorders
Grimaldi, J. A., Bodnar, J., Lavin, D., McLaughlin, M. L., Rasimas, J. J., & Ashley, K. B. (2021) · Springer eBooks · doi:10.1007/978-3-030-80665-1_11 · Cited by 1
Comparison of the effect of two interventions of group dialectical behavior therapy and structured matrix treatment on pathological narcissism and craving for drugs among drug abusers
Basereh, S., Safarzadeh, S., & Hooman, F. (2022) · Journal of Multidisciplinary Care · doi:10.34172/jmdc.2022.43 · Cited by 1
Evaluating and Managing the Agitated Patient
Hong, V., Baumhauer, J., & Leung, S. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197624005.003.0002 · Cited by 1
Predictors of Methamphetamine-Induced Psychosis: A Comparison of Socio-Demographic Factors, Clinical Factors and Psychopathology with Acute Episode Schizophrenia
Razak, N. S. A., Wahab, S. B., Sidi, H., Chemi, N. B., & Ahmad, N. (2023) · International Journal of Academic Research in Business and Social Sciences · doi:10.6007/ijarbss/v13-i6/17569 · Cited by 1
Dopaminergic dominance in the ventral medial hypothalamus: A pivotal regulator for methamphetamine-induced pathological aggression
Zhang, L., Sun, Y., Wang, J., Zhang, M., Wang, Q., Xie, B., Yu, F., Wen, D., & Ma, C. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110971 · Cited by 1
A rare incidence of acute ischaemic stroke with reversible middle cerebral artery occlusion in a methamphetamine addict: Case report
Xue, M., Li, F., Feng, S., Liu, S., & Gao, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29425 · Cited by 1
Prevalence and Characteristics of Delusional Infestation in Individuals With Opiate Use Disorders Within One Health System: A Retrospective Cross-Sectional Study
Shrestha, M., Cox-Davenport, B., Powell, D. L., & Donato, A. A. (2024) · Cureus · doi:10.7759/cureus.76098 · Cited by 1

Authors: Glasner-Edwards, S., & Mooney, L. J.
Affiliations: University of California, Los Angeles (US)
ORCID: Mooney, Larissa J.
Venue: CNS Drugs
Publisher: Springer Science and Business Media LLC
Published: 2014-11-06
Volume: 28
Issue: 12
Pages: 1115-1126
ISSN: 1172-7047 (ISSN-L)
1179-1934
DOI: 10.1007/s40263-014-0209-8
PMC: PMC5027896
OpenAlex: W2035893127
Cited by: 266
References: 97
Citations by year: 2026: 26 · 2025: 28 · 2024: 29 · 2023: 34 · 2022: 31 · 2021: 31 · 2020: 18 · 2019: 19 · 2018: 26 · 2017: 9 · 2016: 12 · 2015: 2 · 2014: 1
FWCI: 6.04
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: CNS Drugs (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (K23DA020085)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords: methamphetamine psychosis, drug-induced psychosis, differential diagnosis, schizophrenia, antipsychotic drugs, benzodiazepines, methamphetamine dependence, psychosocial interventions, relapse prevention, urine toxicology, crisis intervention
MeSH terms: Central Nervous System Stimulants, Humans, Methamphetamine, Psychoses, Substance-Induced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Methamphetamine Psychosis: Epidemiology and Management

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks